We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Roadzen Inc | NASDAQ:RDZN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.088 | 11.28% | 0.868 | 0.84 | 0.98 | 0.842 | 0.7704 | 0.79 | 38,045 | 01:00:00 |
“We closed another solid quarter of year-over-year revenue growth, primarily driven by our U.S. and India markets. This momentum positions us for continued growth in FY25, even as we navigate challenges including the UK’s Financial Conduct Authority’s (“FCA”) temporary, industry-wide pause on automotive GAP insurance product sales in the UK, which had been tracking above $5 million in quarterly revenue for Roadzen. Despite this pause, we have achieved our best first quarter in our history and are confident that European growth will resume in the coming months,” commented Rohan Malhotra, CEO and Founder of Roadzen. “Our drive to profitability is yielding results, with Adjusted EBITDA improvements over the past three quarters. Additionally, we expect to complete the restructuring of our one-time going-public costs and liabilities in the next quarter. This will not only normalize our balance sheet but also allow us to refocus on the excitement surrounding Roadzen’s technology, our strong revenue growth, and the continued addition of marquee global clients over the past year.”
Mr. Malhotra continued, “Looking ahead, I believe that with our leadership in AI, enterprise-focused business model, and operating presence in three of the largest auto insurance markets in the world – the U.S., India, and the U.K./E.U. – Roadzen has the potential to be one of the most exciting insurance technology companies in the public markets.”
Jean-Noël Gallardo, Roadzen’s CFO added, “We have clear goals for our company this year: to simplify and right-size our balance sheet, grow revenues and cut costs, and we have made significant progress this current quarter on achieving these goals. We are emerging from the legacy overhang inherited from the going-public process and are encouraged by the support received from all parties involved. We’re also pleased to have extended the maturity and increased the amount of our senior secured debt with Mizuho through the end of the calendar year, as they remain supportive partners for our growth.”
_________________________1 Adjusted EBITDA is a non-GAAP financial metric. See “Non-GAAP Financial Measures” at the end of this press release for more information, including a reconciliation to the nearest GAAP financial measure.
First Quarter 2024 Financial Highlights:
Revenue and Key Performance Indicators
Expenses and Net Results
First Quarter 2025 Operational Highlights
For more information about Roadzen Inc., please visit https://roadzen.ai
About Roadzen Inc.Roadzen Inc. (Nasdaq: RDZN) is a global technology company transforming auto insurance using advanced artificial intelligence (AI). Thousands of clients, from the world’s leading insurers, carmakers, and fleets to dealerships and auto insurance agents, use Roadzen’s technology to build new products, sell insurance, process claims, and improve road safety. Roadzen’s pioneering work in telematics, generative AI, and computer vision has earned recognition as a top AI innovator by publications such as Forbes, Fortune, and Financial Express. Roadzen’s mission is to continue advancing AI research at the intersection of mobility and insurance, ushering in a world where accidents are prevented, premiums are fair, and claims are processed within minutes, not weeks. Headquartered in Burlingame, California, the Company has 380+ employees across its global offices in the U.S., India, U.K. and France. To learn more, please visit www.roadzen.ai.
Cautionary Statement Regarding Forward-Looking StatementsThis press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “expected,” “committed,” “plan,” “anticipate,” “believe,” “pipeline,” “leads,” “estimate,” and “continue,” or the negative of such terms or other similar expressions. Such statements include, but are not limited to, statements regarding our strategy, demand for our products, expansion plans, future operations, future operating results, planned balance sheet restructuring, estimated revenues (including from new contracts and joint ventures), losses, projected costs, prospects, plans and objectives of management, as well as all other statements other than statements of historical fact included in this press release. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in “Risk Factors” in our Securities and Exchange Commission (“SEC”) filings, including the Annual Report on form 10-K we filed with the SEC on July 1, 2024. We urge you to consider these factors, risks and uncertainties carefully in evaluating the forward-looking statements contained in this press release. All subsequent written or oral forward-looking statements attributable to our company or persons acting on our behalf are expressly qualified in their entirety by these cautionary statements. The forward-looking statements included in this press release are made only as of the date of this release. Except as expressly required by applicable securities law, we disclaim any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Roadzen Inc. | |||||
Condensed Consolidated Balance Sheets (Unaudited) | |||||
(in $, except per share data and share count) | |||||
Particulars | As of June 30, 2024 | As of March 31, 2024 | |||
Assets | |||||
Current assets: | |||||
Cash and cash equivalents | 7,777,413 | 11,186,095 | |||
Accounts receivable, net | 2,669,058 | 3,652,380 | |||
Inventories | 77,399 | 70,667 | |||
Prepayments and other current assets | 15,905,725 | 34,426,335 | |||
Investments | 313,488 | 507,094 | |||
Total current assets | 26,743,083 | 49,842,571 | |||
Restricted cash | 376,981 | 378,993 | |||
Non marketable securities | 1,513,995 | 1,514,796 | |||
Property and equipment, net | 245,062 | 454,589 | |||
Goodwill | 2,061,292 | 2,061,553 | |||
Operating lease right-of-use assets | 981,108 | 822,327 | |||
Intangible assets, net | 2,176,671 | 2,989,604 | |||
Other long-term assets | 44,840 | 71,913 | |||
Total assets | 34,143,032 | 58,136,346 | |||
Liabilities and stockholders' deficit | |||||
Current liabilities | |||||
Current portion of long-term borrowings | 2,225,255 | 2,228,471 | |||
Short-term borrowings | 16,956,691 | 15,754,829 | |||
Due to insurer | 6,637,826 | 8,918,849 | |||
Accounts payable and accrued expenses | 31,545,371 | 29,573,638 | |||
Derivative warrant liabilities | 3,178,756 | 5,585,955 | |||
Short-term operating lease liabilities | 314,675 | 358,802 | |||
Other current liabilities | 3,522,285 | 3,231,962 | |||
Total current liabilities | 64,380,859 | 65,652,506 | |||
Long-term borrowings | 1,366,308 | 1,472,933 | |||
Long-term operating lease liabilities | 508,143 | 268,856 | |||
Other long-term liabilities | 897,207 | 1,241,917 | |||
Total liabilities | 67,152,517 | 68,636,212 | |||
Commitments and contingencies (refer note 21) | |||||
Shareholders' deficit | |||||
Ordinary Shares and additional paid in capital, $0.0001 par value per share, 220,000,000 shares authorized as of June 30 2024 and March 31, 2024; 68,440,829 shares outstanding as of June 30, 2024 and March 31, 2024 | 84,974,378 | 84,974,378 | |||
Accumulated deficit | (199,415,444 | ) | (151,008,419 | ) | |
Accumulated other comprehensive income/(loss) | (885,099 | ) | (600,501 | ) | |
Other components of equity | 82,791,695 | 56,560,706 | |||
Total shareholders’ deficit | (32,534,470 | ) | (10,073,836 | ) | |
Non-controlling interest | (475,015 | ) | (426,030 | ) | |
Total deficit | (33,009,485 | ) | (10,499,866 | ) | |
Total liabilities and Shareholders’ deficit, Non-controlling interest | 34,143,032 | 58,136,346 | |||
Roadzen Inc. | |||||
Condensed Consolidated Statements of Operations (Unaudited) | |||||
(in $, except per share data and share count) | |||||
For the period ended | |||||
Particulars | June 30, 2024 | June 30, 2023 | |||
Revenue | 8,931,517 | 5,610,910 | |||
Costs and expenses: | |||||
Cost of services | 5,427,440 | 2,297,809 | |||
Research and development | 1,789,542 | 573,300 | |||
Sales and marketing | 5,802,298 | 3,659,341 | |||
General and administrative | 25,826,188 | 2,601,983 | |||
Depreciation and amortization | 480,349 | 367,538 | |||
Total costs and expenses | 39,325,817 | 9,499,971 | |||
Loss from operations | (30,394,300 | ) | (3,889,061 | ) | |
Interest income/(expense) | (821,686 | ) | (217,954 | ) | |
Fair value gains/(losses) in financial instruments carried at fair value | (17,152,060 | ) | - | ||
Other income/(expense) net | 22,352 | 62,430 | |||
Total other income/(expense) | (17,951,394 | ) | (155,524 | ) | |
(Loss)/Income before income tax expense | (48,345,694 | ) | (4,044,585 | ) | |
Less: income tax (benefit)/expense | 106,650 | 22,411 | |||
Income tax expense | 12,933 | - | |||
Deferred tax expense | 93,717 | - | |||
Net (loss)/income before non-controlling interest | (48,452,344 | ) | (4,066,996 | ) | |
Net loss attributable to non-controlling interest, net of tax | (45,319 | ) | (27,752 | ) | |
Net (loss)/income attributable to Roadzen Inc. | (48,407,025 | ) | (4,039,244 | ) | |
Net (loss)/income attributable to Roadzen Inc. ordinary shareholders | (48,407,025 | ) | (4,039,244 | ) | |
Basic and diluted | (0.71 | ) | (6.73 | ) | |
Weighted-average number of shares outstanding used to compute net loss per share attributable to Roadzen Inc. ordinary shareholders | 68,440,829 | 606,425 | |||
Roadzen Inc. | |||||
Condensed Consolidated Statements of Cash Flows (Unaudited) | |||||
(in $) | |||||
For the period ended | |||||
Particulars | June 30, 2024 | June 30, 2023 | |||
Cash flows from operating activities | |||||
Net loss including non controlling interest | (48,452,344 | ) | (4,066,996 | ) | |
Adjustments to reconcile net loss to net cash used in operating activities: | |||||
Depreciation and amortization | 480,349 | 367,538 | |||
Stock based compensation | 26,230,989 | - | |||
Deferred income taxes | (37,185 | ) | (26,005 | ) | |
Unrealised foreign exchange loss/(profit) | (3,398 | ) | 11,413 | ||
Fair value losses in financial instruments carried at fair value | 17,152,060 | — | |||
Expected credit loss (net of reversal) | (50,682 | ) | - | ||
Balances written off/(back) | - | (32,778 | ) | ||
Changes in assets and liabilities, net of assets acquired and liabilities assumed from acquisitions: | |||||
Inventories | (6,803 | ) | (18,928 | ) | |
Income taxes, net | - | 19,362 | |||
Accounts receivables, net | 1,037,883 | (2,851,128 | ) | ||
Prepayments and other assets | 1,046,454 | (1,339,900 | ) | ||
Accounts payable and accrued expenses and other current liabilities | (2,767,021 | ) | 7,951,537 | ||
Other liabilities | (296,982 | ) | (2,937,334 | ) | |
Net cash used in operating activities | (5,666,680 | ) | (2,923,219 | ) | |
Cash flows from investing activities | |||||
Purchase of property and equipment, intangible assets and goodwill | 32,745 | 204,329 | |||
Acquisition of businesses | - | (2,720,000 | ) | ||
Proceeds from sale of mutual fund | 193,606 | - | |||
Proceeds from forward purchase agreement | 1,000,000 | - | |||
Net cash used in investing activities | 1,226,351 | (2,515,671 | ) | ||
Cash flows from financing activities | |||||
Proceeds from issue of preferred stock | - | 4,445,027 | |||
Proceeds from long-term borrowings | - | 2,662,590 | |||
Repayments of long-term borrowings | (121,365 | ) | (29,622 | ) | |
Net proceeds/(payments) from short-term borrowings | 1,154,519 | 5,298,782 | |||
Net cash generated from financing activities | 1,033,154 | 12,376,777 | |||
Effect of exchange rate changes on cash and cash equivalents | (3,519 | ) | (31,815 | ) | |
Net (decrease)/increase in cash and cash equivalents (including restricted cash) | (3,410,694 | ) | 6,906,072 | ||
Cash acquired in business combination | - | 11,180,117 | |||
Cash and cash equivalents at the beginning of the period (including restricted cash) | 11,565,088 | 1,131,831 | |||
Cash and cash equivalents at the end of the period (including restricted cash) | 8,154,394 | 19,218,020 | |||
Reconciliation of cash and cash equivalents | |||||
Cash and cash equivalents | 7,777,413 | 18,674,424 | |||
Restricted cash | 376,981 | 543,596 | |||
Total cash and cash equivalents | 8,154,394 | 19,218,020 | |||
Supplemental disclosure of cash flow information | |||||
Cash paid for interest, net of amounts capitalized | 391,829 | 123,180 | |||
Cash paid for income taxes, net of refunds | - | 84,197 | |||
Non-cash investing and financing activities | |||||
Consideration payable in connection with acquisitions | 488,000 | 3,621,531 | |||
Interest accrued on borrowings | 790,395 | 143,278 | |||
Non-GAAP Financial MeasuresThis press release includes Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (“Adjusted EBITDA”), a non-GAAP financial measure which excludes the impact of finance costs, taxes, depreciation and amortization and certain other items from reported net profit or loss. We believe that Adjusted EBITDA aids investors by providing an operating profit/loss without the impact of non-cash depreciation and amortization and certain non-recurring and other items to help clarify sustainability and trends affecting the business. For comparability of reporting, management considers non-GAAP measures in conjunction with U.S. GAAP financial results in evaluating business performance. Adjusted EBITDA should not be considered a substitute for, or superior to, the measures of financial performance prepared in accordance with U.S. GAAP. In addition, Adjusted EBITDA does not purport to represent cash flows provided by, or used for, operating activities in accordance with GAAP and should not be used as a measure of liquidity.
Non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as substitutes for financial information presented under GAAP. There are a number of limitations related to the use of non-GAAP financial measures versus comparable financial measures determined under GAAP. For example, other companies in our industry may calculate these non-GAAP financial measures differently or may use other measures to evaluate their performance. These limitations could reduce the usefulness of these non-GAAP financial measures as analytical tools. Investors are encouraged to review the related GAAP financial measures and the reconciliations of these non-GAAP financial measures to their most directly comparable GAAP financial measures and to not rely on any single financial measure to evaluate our business.
The following table reconciles our net loss reported in accordance with U.S. GAAP to Adjusted EBITDA:
For the three months ended June 30, | ||||
Particulars | 2024 | 2023 | ||
Net loss | (48,452,344 | ) | (4,066,996 | ) |
Adjusted for: | ||||
Other (income)/expense net | (22,352 | ) | (62,430 | ) |
Interest (income)/expense | 821,686 | 217,954 | ||
Fair value changes in financial instruments carried at fair value | 17,152,060 | - | ||
Tax (benefit)/expense | 106,650 | 22,411 | ||
Depreciation and amortization | 480,349 | 367,538 | ||
Stock based compensation expense | 26,230,989 | - | ||
Non-cash expenses | 285,060 | - | ||
Non-recurring expenses | 524,758 | 1,819,746 | ||
Adjusted EBITDA | (2,873,144 | ) | (1,701,777 | ) |
For more information, please contact:Investor Contacts:IR@roadzen.ai
Media Contacts:Roadzen: Sanya Soni sanya@roadzen.ai or media@roadzen.aiGutenberg: roadzen@thegutenberg.com
1 Year Roadzen Chart |
1 Month Roadzen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions